SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 77 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q3 2014. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $4,000 | -94.2% | 38,418 | -5.5% | 0.00% | – |
Q3 2018 | $69,000 | -2.8% | 40,634 | 0.0% | 0.00% | – |
Q2 2018 | $71,000 | -15.5% | 40,634 | -12.0% | 0.00% | – |
Q1 2018 | $84,000 | -39.6% | 46,187 | -25.3% | 0.00% | – |
Q4 2017 | $139,000 | -21.0% | 61,803 | +0.2% | 0.00% | – |
Q3 2017 | $176,000 | -29.3% | 61,701 | +9.5% | 0.00% | – |
Q2 2017 | $249,000 | +7.8% | 56,358 | +13.9% | 0.00% | – |
Q1 2017 | $231,000 | -13.2% | 49,476 | +12.2% | 0.00% | – |
Q4 2016 | $266,000 | +91.4% | 44,109 | +68.1% | 0.00% | – |
Q3 2016 | $139,000 | +27.5% | 26,236 | -10.6% | 0.00% | – |
Q2 2016 | $109,000 | +118.0% | 29,343 | +60.0% | 0.00% | – |
Q1 2016 | $50,000 | -51.9% | 18,342 | 0.0% | 0.00% | – |
Q4 2015 | $104,000 | +4.0% | 18,342 | 0.0% | 0.00% | – |
Q3 2015 | $100,000 | -32.4% | 18,342 | 0.0% | 0.00% | – |
Q2 2015 | $148,000 | +82.7% | 18,342 | 0.0% | 0.00% | – |
Q1 2015 | $81,000 | +44.6% | 18,342 | 0.0% | 0.00% | – |
Q4 2014 | $56,000 | +7.7% | 18,342 | 0.0% | 0.00% | – |
Q3 2014 | $52,000 | – | 18,342 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 3,273,509 | $9,493,000 | 1.85% |
Trellus Management Company, LLC | 362,500 | $1,051,000 | 1.44% |
Paulson & Co. | 24,062,368 | $69,781,000 | 1.25% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 971,922 | $2,799,000 | 1.09% |
Asymmetry Capital Management, L.P. | 271,102 | $786,000 | 0.91% |
Cheyne Capital Management (UK) LLP | 651,500 | $1,880,000 | 0.68% |
Hikari Power Ltd | 1,500,000 | $4,350,000 | 0.56% |
Orbimed Advisors | 13,621,443 | $39,502,000 | 0.38% |
CARL DOMINO INC | 83,000 | $241,000 | 0.29% |
KNOTT DAVID M | 158,400 | $459,000 | 0.20% |